Latest news
Standard BioTools (LAB) Stock Rebound Leaves Revenue Slide And Losses In Focus - simplywall.stsimplywall.st · Fri, 07 Aug 2026 01:53:53 GMTStandard BioTools Q2 Results Highlight Strategic Restructuring - TipRanksTipRanks · Thu, 06 Aug 2026 02:56:18 GMTStandard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 22:50:26 GMTSTANDARD BIOTOOLS INC. Q2 2026: Revenue $20.1M, EPS $(0.07) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:26:35 GMTStandard BioTools: Q2 Earnings Snapshot - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 20:25:01 GMTStandard BioTools (NASDAQ: LAB) nets $388M cash from Illumina deal - Stock TitanStock Titan · Wed, 05 Aug 2026 20:12:22 GMTStandard BioTools Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 20:11:00 GMTStandard BioTools (LAB) CEO has 362,625 shares withheld for taxes - Stock TitanStock Titan · Tue, 04 Aug 2026 22:01:45 GMT